PIM1-IN-2(Cat No.:R029067)is a selective small-molecule inhibitor of PIM1 kinase, a serine/threonine kinase implicated in cell survival, proliferation, and oncogenesis. By blocking PIM1 activity, PIM1-IN-2 disrupts phosphorylation of downstream targets involved in cell cycle progression and anti-apoptotic signaling. It is widely used in cancer research to investigate the role of PIM1 in hematologic malignancies and solid tumors. PIM1-IN-2 aids in exploring kinase-driven oncogenic pathways and evaluating targeted therapeutic strategies. Its specificity makes it a valuable tool for studying PIM1’s biological functions and its potential as a drug target in oncology.